# OPLAH

## Overview
The OPLAH gene encodes the enzyme 5-oxoprolinase, ATP-hydrolysing, which is a crucial component of the gamma-glutamyl cycle, a metabolic pathway involved in the synthesis and degradation of glutathione, an essential antioxidant in human cells. This enzyme is categorized as a hydrolase and is responsible for catalyzing the conversion of 5-oxoproline to glutamate, thereby playing a significant role in maintaining cellular redox balance and preventing oxidative stress (van2018OPLAH; Almaghlouth20115‐Oxoprolinase). The proper functioning of 5-oxoprolinase is vital for cellular homeostasis, as it prevents the accumulation of 5-oxoproline, which can lead to oxidative damage if not adequately metabolized (van2018OPLAH). Mutations in the OPLAH gene can result in 5-oxoprolinase deficiency, a rare autosomal recessive disorder with a range of clinical manifestations, highlighting the enzyme's importance in human health (Kasapkara2024Is; Li2015Five).

## Function
The OPLAH gene encodes the enzyme 5-oxoprolinase, which plays a critical role in the gamma-glutamyl cycle, a metabolic pathway essential for the synthesis and degradation of glutathione, a key antioxidant in human cells (Almaghlouth20115‐Oxoprolinase; Sass2016Unravelling). This enzyme catalyzes the conversion of 5-oxoproline to glutamate, a crucial step in the recycling of glutathione, thereby maintaining cellular redox balance and preventing oxidative stress (van2018OPLAH; Calpena2014New). 

In healthy human cells, OPLAH is active in the cytoplasm, where it helps maintain amino acid homeostasis and supports various cellular processes, including detoxification and antioxidant defense (van2018OPLAH). The enzyme's activity is vital for preventing the accumulation of 5-oxoproline, which can induce oxidative stress if not properly metabolized (van2018OPLAH). 

The proper functioning of OPLAH is crucial for cardiovascular health, as its deficiency is associated with increased oxidative stress and potential heart failure (van2017Accumulation). Overall, OPLAH's role in the gamma-glutamyl cycle underscores its importance in maintaining cellular homeostasis and protecting against oxidative damage.

## Clinical Significance
Mutations in the OPLAH gene, which encodes the enzyme 5-oxoprolinase, lead to 5-oxoprolinase deficiency, a rare autosomal recessive disorder. This condition is characterized by the accumulation of 5-oxoproline, resulting in 5-oxoprolinuria. Clinically, the disorder presents with a range of symptoms, including neonatal hypoglycemia, microcytic anemia, microcephaly, recurrent vomiting, psychomotor retardation, and renal stone formation (Kasapkara2024Is; Li2015Five). The deficiency can also cause neurological symptoms such as epilepsy, speech difficulties, and cerebral atrophy (Kasapkara2024Is).

The clinical presentation of 5-oxoprolinase deficiency is heterogeneous, with some cases being largely benign, while others involve significant neurological impairment (Almaghlouth20115‐Oxoprolinase). The condition is part of the gamma-glutamyl cycle, crucial for glutathione synthesis and degradation, and is associated with oxidative stress and impaired energy metabolism in neural cells (Li2015Five).

Despite being previously considered a benign biochemical condition, recent studies suggest that 5-oxoprolinase deficiency may have more significant clinical implications than previously thought (Kasapkara2024Is). There is no effective therapy other than symptomatic treatment, and urine 5-oxoproline levels do not decrease following treatment (Li2015Five).


## References


[1. (van2017Accumulation) Atze van der Pol, Andres Gil, Herman H. W. Silljé, Jasper Tromp, Ekaterina S. Ovchinnikova, Inge Vreeswijk-Baudoin, Martijn Hoes, Ibrahim J. Domian, Bart van de Sluis, Jan M. van Deursen, Adriaan A. Voors, Dirk J. van Veldhuisen, Wiek H. van Gilst, Eugene Berezikov, Pim van der Harst, Rudolf A. de Boer, Rainer Bischoff, and Peter van der Meer. Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of oplah. Science Translational Medicine, November 2017. URL: http://dx.doi.org/10.1126/scitranslmed.aam8574, doi:10.1126/scitranslmed.aam8574. This article has 39 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/scitranslmed.aam8574)

[2. (Kasapkara2024Is) Çiğdem Seher Kasapkara, Oya Kıreker Köylü, Aysenur Engin Erdal, Burak Yürek, Nesrin Ceylan, and Serdar Ceylaner. Is 5-oxoprolinase deficiency more than just a benign condition? Molecular Syndromology, 15(4):303–310, 2024. URL: http://dx.doi.org/10.1159/000536295, doi:10.1159/000536295. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1159/000536295)

[3. (Almaghlouth20115‐Oxoprolinase) IA Almaghlouth, JY Mohamed, M Al‐Amoudi, L Al‐Ahaidib, A Al‐Odaib, and FS Alkuraya. 5‐oxoprolinase deficiency: report of the first human oplah mutation. Clinical Genetics, 82(2):193–196, June 2011. URL: http://dx.doi.org/10.1111/j.1399-0004.2011.01728.x, doi:10.1111/j.1399-0004.2011.01728.x. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/j.1399-0004.2011.01728.x)

[4. (Sass2016Unravelling) Jörn Oliver Sass, Corinne Gemperle-Britschgi, Maja Tarailo-Graovac, Nisha Patel, Melanie Walter, Albena Jordanova, Majid Alfadhel, Ivo Barić, Mahmut Çoker, Aynur Damli-Huber, Eissa Ali Faqeih, Nuria García Segarra, Michael T. Geraghty, Bjørn Magne Jåtun, Sema Kalkan Uçar, Merten Kriewitz, Markus Rauchenzauner, Karmen Bilić, Ivailo Tournev, Claudia Till, Bryan Sayson, Daniel Beumer, Cynthia Xin Ye, Lin-Hua Zhang, Hilary Vallance, Fowzan S. Alkuraya, and Clara D.M. van Karnebeek. Unravelling 5-oxoprolinuria (pyroglutamic aciduria) due to bi-allelic oplah mutations: 20 new mutations in 14 families. Molecular Genetics and Metabolism, 119(1–2):44–49, September 2016. URL: http://dx.doi.org/10.1016/j.ymgme.2016.07.008, doi:10.1016/j.ymgme.2016.07.008. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2016.07.008)

[5. (Calpena2014New) Eduardo Calpena, Anup Arunrao Deshpande, Sufin Yap, Akhilesh Kumar, Nigel J. Manning, Anand K. Bachhawat, and Carmen Espinós. New insights into the genetics of 5-oxoprolinase deficiency and further evidence that it is a benign biochemical condition. European Journal of Pediatrics, 174(3):407–411, August 2014. URL: http://dx.doi.org/10.1007/s00431-014-2397-0, doi:10.1007/s00431-014-2397-0. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00431-014-2397-0)

[6. (van2018OPLAH) Atze van der Pol, Andres Gil, Jasper Tromp, Herman H W Silljé, Dirk J van Veldhuisen, Adriaan A Voors, Elke S Hoendermis, Niels Grote Beverborg, Elisabeth-Maria Schouten, Rudolf A de Boer, Rainer Bischoff, and Peter van der Meer. Oplah ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction. Cardiovascular Research, 114(14):1871–1882, July 2018. URL: http://dx.doi.org/10.1093/cvr/cvy187, doi:10.1093/cvr/cvy187. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/cvr/cvy187)

[7. (Li2015Five) Xiyuan Li, Yuan Ding, Yupeng Liu, Yanyan Ma, Jinqing Song, Qiao Wang, and Yanling Yang. Five chinese patients with 5-oxoprolinuria due to glutathione synthetase and 5-oxoprolinase deficiencies. Brain and Development, 37(10):952–959, November 2015. URL: http://dx.doi.org/10.1016/j.braindev.2015.03.005, doi:10.1016/j.braindev.2015.03.005. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.braindev.2015.03.005)